YaoGeJu

Company directoryChina company filings

Beijing Scrianen Pharmaceutical Co.,Ltd.

As of 20 November 2026, for the company name Beijing Scrianen Pharmaceutical Co.,Ltd. as recorded, 3 applications with this name as first applicant are listed as under review at China's CDE; the CDE acceptance records name it as first applicant on 25 records, across 18 drug names; since 24 August 2026, the records list Accepted: 1 application; the chemical-drug catalogue lists 8 active records with this name as holder; 29 active API registrations list this name as first registered company; 1 further acceptance record names it after the first applicant.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/20
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/20.

Drug filings

25 acceptance records as first applicant, grouped into 18 source drug names. Source data as of 2026/11/20.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

Rosuvastatin Calcium and Ezetimibe Tablets (I) 1 records · Latest accepted 2026/11/17

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2602825Generic2026/11/17Beijing Scrianen Pharmaceutical Co.,Ltd.CDE ↗
Z21204 · No verified English name 1 records · Latest accepted 2026/07/28

New drug · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXHL2600919New drug2026/07/28Beijing Scrianen Pharmaceutical Co.,Ltd.CDE ↗
氯喹那多-普罗雌烯阴道片 · No verified English name 2 records · Latest accepted 2026/03/18

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2600528Supplement2026/03/18Beijing Scrianen Pharmaceutical Co.,Ltd.CDE ↗
CYHB2202011Supplement2022/11/02Beijing Scrianen Pharmaceutical Co.,Ltd.CDE ↗
L-5-甲基四氢叶酸钙片 · No verified English name 1 records · Latest accepted 2026/03/11

New drug · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXHL2600291New drug2026/03/11Beijing Scrianen Pharmaceutical Co.,Ltd.CDE ↗
Medroxyprogesterone Acetate Tablets 2 records · Latest accepted 2026/01/10

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2600044Supplement2026/01/10Beijing Scrianen Pharmaceutical Co.,Ltd.CDE ↗
CYHB2200170Supplement2022/01/20Beijing Scrianen Pharmaceutical Co.,Ltd.CDE ↗
Betaine anhydrous for oral solution 3 records · Latest accepted 2025/12/24

Generic · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2504363Generic2025/12/24Beijing Scrianen Pharmaceutical Co.,Ltd.CDE ↗
CYHL2400157Generic2024/07/26Beijing Scrianen Pharmaceutical Co.,Ltd.CDE ↗
CYHS2400282Generic2024/01/20Beijing Scrianen Pharmaceutical Co.,Ltd.CDE ↗
参榆消银软膏 · No verified English name 1 records · Latest accepted 2025/07/05

New drug · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXZL2500044New drug2025/07/05Beijing Scrianen Pharmaceutical Co.,Ltd.CDE ↗
Dydrogesterone Tablets 1 records · Latest accepted 2025/06/25

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2502270Generic2025/06/25Beijing Scrianen Pharmaceutical Co.,Ltd.CDE ↗
Ethyl Iosapentate Capsules 1 records · Latest accepted 2025/06/05

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2501995Generic2025/06/05Beijing Scrianen Pharmaceutical Co.,Ltd.CDE ↗
Eldecalcitol Soft Capsules 1 records · Latest accepted 2024/12/09

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2404255Generic2024/12/09Beijing Scrianen Pharmaceutical Co.,Ltd.CDE ↗
Vonoprazan Fumarate Tablets 2 records · Latest accepted 2024/09/28

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2403285Generic2024/09/28Beijing Scrianen Pharmaceutical Co.,Ltd.CDE ↗
CYHS2403284Generic2024/09/28Beijing Scrianen Pharmaceutical Co.,Ltd.CDE ↗
根痛平丸 · No verified English name 1 records · Latest accepted 2024/08/26

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYZB2401597Supplement2024/08/26Beijing Scrianen Pharmaceutical Co.,Ltd.CDE ↗
Folic Acid Tablets 3 records · Latest accepted 2024/07/10

New drug · 2Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXHL2400681New drug2024/07/10Beijing Scrianen Pharmaceutical Co.,Ltd.CDE ↗
CXHL2200594New drug2022/08/18Beijing Scrianen Pharmaceutical Co.,Ltd.CDE ↗
CYHS2201324Generic2022/08/17Beijing Scrianen Pharmaceutical Co.,Ltd.CDE ↗
Ferrous Succinate Tablets 1 records · Latest accepted 2024/04/10

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2401069Generic2024/04/10Beijing Scrianen Pharmaceutical Co.,Ltd.CDE ↗
根痛平片 · No verified English name 1 records · Latest accepted 2023/06/29

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYZB2301176Supplement2023/06/29Beijing Scrianen Pharmaceutical Co.,Ltd.CDE ↗
Oseltamivir Phosphate For Oral Suspension 1 records · Latest accepted 2023/04/04

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2300958Generic2023/04/04Beijing Scrianen Pharmaceutical Co.,Ltd.CDE ↗
Mecobalamin Tablets 1 records · Latest accepted 2022/03/29

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2200495Generic2022/03/29Beijing Scrianen Pharmaceutical Co.,Ltd.CDE ↗
Trihexyphenidyl Hydrochloride Tablets 1 records · Latest accepted 2021/11/02

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2101959Generic2021/11/02Beijing Scrianen Pharmaceutical Co.,Ltd.CDE ↗

Changes in the last 90 days

1 events from 2026/08/24 to 2026/11/21. CDE data as of 2026/11/20; NMPA data as of 2026/11/20.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Accepted: 1 application

  1. 2026/11/17Accepted

    Rosuvastatin Calcium and Ezetimibe Tablets (I)

    CYHS2602825

    Fact date: 2026/11/17 · Date added to this site: 2026/11/18

    View source ↗

Under review

3 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/20.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Rosuvastatin Calcium and Ezetimibe Tablets (I) CYHS2602825Generic2026/11/17Beijing Scrianen Pharmaceutical Co.,Ltd.CDE ↗
Dydrogesterone Tablets CYHS2502270Generic2025/06/25Beijing Scrianen Pharmaceutical Co.,Ltd.CDE ↗
Ethyl Iosapentate Capsules CYHS2501995Generic2025/06/05Beijing Scrianen Pharmaceutical Co.,Ltd.CDE ↗

Catalogue holder records

8 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/20. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerNMPA approval no.ApprovedCatalogue category (source text)View source
Vonoprazan Fumarate TabletsBeijing Scrianen Pharmaceutical Co.,Ltd.Beijing Scrianen Pharmaceutical Co.,Ltd.国药准字H202644062026/05/19Generic approved under the new chemical-drug registration classificationCDE ↗
Eldecalcitol Soft CapsulesBeijing Scrianen Pharmaceutical Co.,Ltd.Beijing Scrianen Pharmaceutical Co.,Ltd.国药准字H202643572026/05/19Generic approved under the new chemical-drug registration classificationCDE ↗
Vonoprazan Fumarate TabletsBeijing Scrianen Pharmaceutical Co.,Ltd.Beijing Scrianen Pharmaceutical Co.,Ltd.国药准字H202644072026/05/19Generic approved under the new chemical-drug registration classificationCDE ↗
Ferrous Succinate TabletsBeijing Scrianen Pharmaceutical Co.,Ltd.Beijing Scrianen Pharmaceutical Co.,Ltd.国药准字H202640432026/04/21Generic approved under the new chemical-drug registration classificationCDE ↗
Oseltamivir Phosphate For Oral SuspensionBeijing Scrianen Pharmaceutical Co.,Ltd.Beijing Scrianen Pharmaceutical Co.,Ltd.国药准字H202495502024/12/01Generic approved under the new chemical-drug registration classificationCDE ↗
Mecobalamin TabletsBeijing Scrianen Pharmaceutical Co.,Ltd.Beijing Scrianen Pharmaceutical Co.,Ltd.国药准字H202447782024/09/03Generic approved under the new chemical-drug registration classificationCDE ↗
Trihexyphenidyl Hydrochloride TabletsBeijing Scrianen Pharmaceutical Co.,Ltd.Beijing Scrianen Pharmaceutical Co.,Ltd.国药准字H202336202023/05/29Generic approved under the new chemical-drug registration classificationCDE ↗
甜菜碱散 · No verified English nameBeijing Scrianen Pharmaceutical Co.,Ltd.Beijing Scrianen Pharmaceutical Co.,Ltd.国药准字H202657722026/08/25Generic approved under the new chemical-drug registration classificationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

29 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/20.

NameCompany / applicantRegistration numberStatusSource update dateView source
无水磷酸氢钙 · No verified English nameBeijing Scrianen Pharmaceutical Co.,Ltd.Y20250001482I2026/01/07CDE ↗
甜菜碱 · No verified English nameBeijing Scrianen Pharmaceutical Co.,Ltd.Y20250001245A2026/11/11CDE ↗
醋酸甲羟孕酮 · No verified English nameBeijing Scrianen Pharmaceutical Co.,Ltd.Y20250000959I2025/09/08CDE ↗
哌柏西利 · No verified English nameBeijing Scrianen Pharmaceutical Co.,Ltd.Y20250000364I2025/04/21CDE ↗
L-5-甲基四氢叶酸钙 · No verified English nameBeijing Scrianen Pharmaceutical Co.,Ltd.Y20240000669I2024/08/21CDE ↗
磷酸氢镁 · No verified English nameBeijing Scrianen Pharmaceutical Co.,Ltd.Y20240000803A2026/05/18CDE ↗
硫酸锰 · No verified English nameBeijing Scrianen Pharmaceutical Co.,Ltd.Y20240000484A2026/01/22CDE ↗
盐酸左沙丁胺醇 · No verified English nameBeijing Scrianen Pharmaceutical Co.,Ltd.Y20230000610A2026/05/20CDE ↗
乙酰唑胺 · No verified English nameBeijing Scrianen Pharmaceutical Co.,Ltd.Y20190007719A2024/11/07CDE ↗
丁酸氢化可的松 · No verified English nameBeijing Scrianen Pharmaceutical Co.,Ltd.Y20190006953A2023/03/24CDE ↗
异环磷酰胺 · No verified English nameBeijing Scrianen Pharmaceutical Co.,Ltd.Y20190006010A—CDE ↗
氯喹那多 · No verified English nameBeijing Scrianen Pharmaceutical Co.,Ltd.Y20190006009A2026/06/16CDE ↗
叶酸 · No verified English nameBeijing Scrianen Pharmaceutical Co.,Ltd.Y20190006007A2023/03/24CDE ↗
普罗雌烯 · No verified English nameBeijing Scrianen Pharmaceutical Co.,Ltd.Y20190003572A2025/03/05CDE ↗
硫酸鱼精蛋白 · No verified English nameBeijing Scrianen Pharmaceutical Co.,Ltd.Y20190003553A2025/03/05CDE ↗
盐酸尼莫司汀 · No verified English nameBeijing Scrianen Pharmaceutical Co.,Ltd.Y20190003543A—CDE ↗
伊来西胺 · No verified English nameBeijing Scrianen Pharmaceutical Co.,Ltd.Y20190002226A2024/08/21CDE ↗
枸橼酸他莫昔芬 · No verified English nameBeijing Scrianen Pharmaceutical Co.,Ltd.Y20190001693A—CDE ↗
左旋多巴 · No verified English nameBeijing Scrianen Pharmaceutical Co.,Ltd.Y20190001692A—CDE ↗
甘氨酸 · No verified English nameBeijing Scrianen Pharmaceutical Co.,Ltd.Y20190001691A—CDE ↗
盐酸安西他滨 · No verified English nameBeijing Scrianen Pharmaceutical Co.,Ltd.Y20190001690A2024/08/21CDE ↗
盐酸苯海索 · No verified English nameBeijing Scrianen Pharmaceutical Co.,Ltd.Y20190001689A2025/09/26CDE ↗
硝苯地平 · No verified English nameBeijing Scrianen Pharmaceutical Co.,Ltd.Y20190001688A—CDE ↗
氟尿嘧啶 · No verified English nameBeijing Scrianen Pharmaceutical Co.,Ltd.Y20190001685A2024/12/27CDE ↗
盐酸阿糖胞苷 · No verified English nameBeijing Scrianen Pharmaceutical Co.,Ltd.Y20190001683A2023/08/10CDE ↗
磺胺甲噁唑 · No verified English nameBeijing Scrianen Pharmaceutical Co.,Ltd.Y20190001682A—CDE ↗
环磷酰胺 · No verified English nameBeijing Scrianen Pharmaceutical Co.,Ltd.Y20190001681A2024/08/21CDE ↗
甲氨蝶呤 · No verified English nameBeijing Scrianen Pharmaceutical Co.,Ltd.Y20190001680A2024/08/16CDE ↗
葡萄糖酸锌 · No verified English nameBeijing Scrianen Pharmaceutical Co.,Ltd.Y20190001662A2025/04/17CDE ↗

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

1 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/20.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Folic Acid Tablets CYHS2502979Generic2025/08/14Jian Chang Bang Pharma Co., Ltd. romanized; Beijing Scrianen Pharmaceutical Co.,Ltd.CDE ↗

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/20
Chemical-drug catalogue
Last successful update: 2026/11/20
API registrations
Last successful update: 2026/11/20
NMPA drug delivery notices
Last successful update: 2026/11/20

Loaded notices dated 2026-11-06 to 2026-11-20; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.